Orion Health™ Shares Vision for Coordinated Care at HIMSS Turkey

Orion HealthOrion Health, a global provider of healthcare integration solutions, recognises Turkey's commitment to improve its healthcare sector and recommends the scope for coordinated care be expanded to meet the needs of people living with long-term conditions.

"Turkey faces similar healthcare challenges as other developing economies including rising healthcare costs, a sharp increase in its elderly population and the growing issues around management of long-term conditions," said Dr. Beyza Akbasoglu, Orion Health country manager for Turkey.

"The country's unparalleled investments in its healthcare providers and professionals will help improve the quality and safety of healthcare services to its growing population. With healthcare spending expected to triple over the next decade, the forecasted USD 63 billion investment will help respond to the need for more than 95,000 new hospital beds by 2024, supporting the growing requirements of Turkey's acute sector."

"As Europe's fastest growing economy, Turkey will need to rely on the provision of homecare, remote monitoring and advanced coordinated care if it wants to keep healthcare costs to a minimum and the quality of care at a high standard," said David Hancock, head of strategy EMEA at Orion Health.

Orion Health participated in a workgroup that supported HIMSS Europe in the development of a new HIMSS model that addresses the importance of such provisions across healthcare organisations.

Hancock continued: "The new HIMSS Continuity of Care Maturity Model will contribute to the goal of managing the care and wellness of citizens especially those with long-term conditions to ensure they are treated in a way that keeps them economically active whilst maintaining a high quality of life for each one of them."

The model is designed for the acute and primary sectors and includes seven stages, from basic peer-to-peer data exchange (stage one) to knowledge driven engagement for a multi-vendor, multi-organisation interconnected health delivery model (stage seven).

The company believes that a continuity of care approach is vital to address the shift from hospital-based to home-based care and, to meet the number of challenges that countries like Turkey are facing.

David Hancock will be speaking at HIMSS in Turkey on June 4that 15:30 as part of a presentation entitled, 'Homecare, Remote Monitoring and Healthy Life Solutions'. The session will include practical advice and examples of how such solutions that maintain healthy lifestyles can empower citizens, improve outcomes and help healthcare organisations to advance their progress on the new HIMSS Continuity of Care Maturity Model.

Visit Orion Health on stand 122 at HIMSS Turkey on June 4-5th or attend David Hancock's presentation to learn more about the benefits of coordinated care in Turkey's growing healthcare sector.

Orion Health operates across more than 30 countries globally and includes a Turkish base to service the whole Eurasia region.

Related news articles:

About Orion Health Ltd
Orion Health is a global, independently owned eHealth software company and is one of the world's leading providers of electronic health records (EHRs) and healthcare integration solutions to healthcare organisations. Worldwide, Orion Health products and solutions are implemented in more than 30 countries, and used by organisations throughout the National Health Service in England and Health and Social Care Northern Ireland, as well as Scotland’s NHS Greater Glasgow and Clyde.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...